Silencing or inhibition of MAT2A results in cell death selectively in MTAP‐deleted cancers via the block of SAM biosynthesis, but exhibits limited influence on normal cells with a reduced concentration of intracellular MTA.11, 12. The gene discussed is MAT2A; the disease is cancer.